ES8404188A1 - Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis. - Google Patents

Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.

Info

Publication number
ES8404188A1
ES8404188A1 ES515472A ES515472A ES8404188A1 ES 8404188 A1 ES8404188 A1 ES 8404188A1 ES 515472 A ES515472 A ES 515472A ES 515472 A ES515472 A ES 515472A ES 8404188 A1 ES8404188 A1 ES 8404188A1
Authority
ES
Spain
Prior art keywords
hepatitis
vaccine
albumin
polymerized
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515472A
Other languages
English (en)
Other versions
ES515472A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of ES8404188A1 publication Critical patent/ES8404188A1/es
Publication of ES515472A0 publication Critical patent/ES515472A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UNA VACUNA DE UTILIDAD PARA LA VACUNACION DE UN ANFITRION MAMIFERO CONTRA LA HEPATITIS.CONSISTE EN COMBINAR ALBUMINA DE SUERO POLIMERIZADA CON UN ADYUVANTE INMUNOGENICO, TENIENDO DICHA ALBUMINA DE SUERO POLIMERIZADA DE 6 A 12 UNIDADES APROXIMADAMENTE, Y ESTANDO SUSTANCIALMENTE LIBRE DE OTRAS PROTEINAS Y MATERIALES GENETICOS DERIVADOS DE VIRUS HEPATOTROPICOS. LA ALBUMINA DE SUERO POLIMERIZADA SE FRACCIONA PARA ASEGURAR EL TAMAÑO ADECUADO ANTES DE LA COMBINACION CON EL ADYUVANTE.
ES515472A 1981-09-04 1982-09-03 Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis. Granted ES515472A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29945281A 1981-09-04 1981-09-04

Publications (2)

Publication Number Publication Date
ES8404188A1 true ES8404188A1 (es) 1984-04-16
ES515472A0 ES515472A0 (es) 1984-04-16

Family

ID=23154848

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515472A Granted ES515472A0 (es) 1981-09-04 1982-09-03 Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.

Country Status (6)

Country Link
EP (1) EP0074248B1 (es)
JP (1) JPS5883631A (es)
AT (1) ATE18007T1 (es)
AU (1) AU554859B2 (es)
DE (1) DE3269188D1 (es)
ES (1) ES515472A0 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248565B (it) * 1991-06-27 1995-01-19 Erba Carlo Spa Anticorpi policlonali anti-irudina e loro utilizzo per la identificazione, l`immunopurificazione e la determinazione quantitativa dell`uridina.
US6719975B1 (en) 1991-06-27 2004-04-13 Farmitalia Carlo Erba S.R.L. Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin
US6682746B2 (en) 1995-09-21 2004-01-27 Kristina J. Hennessy Adjuvanted vaccine which is substantially free of non-host albumin
CA2184132C (en) 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
ES2330904B1 (es) 2005-09-21 2010-09-23 Fundacio Centre De Recerca En Sanitat Animal Polinucleotidos de haemophilus parasuis y su uso.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046871A (en) * 1975-04-08 1977-09-06 Ortho Diagnostics Inc. Compositions and serological methods including bovine serum albumin polymers

Also Published As

Publication number Publication date
EP0074248A2 (en) 1983-03-16
AU8778582A (en) 1983-03-10
EP0074248B1 (en) 1986-02-19
JPS5883631A (ja) 1983-05-19
AU554859B2 (en) 1986-09-04
EP0074248A3 (en) 1983-09-28
DE3269188D1 (en) 1986-03-27
ATE18007T1 (de) 1986-03-15
ES515472A0 (es) 1984-04-16

Similar Documents

Publication Publication Date Title
GB2189143B (en) Immunological adjuvants for polysaccharide vaccines
EP0200412A3 (en) Method of conferring immunotolerance to a specific antigen
MY110665A (en) Combined vaccines comprising hepatitis b surface antigen and other antigen
ATE162402T1 (de) Oraler an der oberfläche von erythrozyten gebundene antigene beinhaltender impfstoff
DK0636031T3 (es)
EA199800272A1 (ru) Фактор, стимулирующий дендритные клетки
EP0283505A4 (en) VACCINE AND PRODUCTION METHOD.
EP0135841A3 (en) Herpes simplex virus subunit vaccine
IL82235A (en) Immunogen complexes, their preparation and vaccines comprising them
EP0261589A3 (en) Polymaleic acid, process for preparing polymaleic acid and its use
ES2036179T3 (es) Procedimiento para preparar monohidrato de hidrocloruro de (s)-(-)-1-propil-2',6'-pipecoloxilidida.
ZA784324B (en) High molecular weight meningococcal group c vaccine and method for preparation thereof
ES8404188A1 (es) Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.
JPS52139713A (en) Sustained release cefalexin preparations
NZ221227A (en) Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods
DK196687A (da) Kombineret vaccine, samt fremgangsmaade til fremstilling deraf
AU2549584A (en) Enhancing vaccines: antigenicity
EP0290565A4 (en) VACCINE CONTAINING TICK ANTIGENS.
AU7121487A (en) Methods and compositions relating to regression-associated antigens
JPS51140245A (en) Solar heat collector and regenerator
EP0367302A3 (en) Process for semi-synthesis of human insulin, water-soluble cross-linked achromobacter protease i for use therein and a process for preparing the same
AU7008687A (en) Improvements in and relating to vaccines
EP0309898A3 (en) Method for the induction of a cytotoxic t cell response
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
JPS5222665A (en) Disc brake